中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 40 Issue 7
Jul.  2024
Turn off MathJax
Article Contents

Association between sleep disorders and different stages of nonalcoholic fatty liver disease

DOI: 10.12449/JCH240712
Research funding:

Capital’s Funds for Health Improvement and Research (CFH2022-2-20213);

Capital’s Funds for Health Improvement and Research (CFH2022-1-2021);

Beijing Key Project of Major Disease by Chinese Medicine and Western Medicine (2023BJSZDYNJBXTGG-017);

Beijing High-level Public Health Technical Personnel Construction Project (Discipline Backbone-03-40)

More Information
  • Corresponding author: YOU Hong, youhongliver@ccmu.edu.cn (ORCID: 0000-0001-9409-1158)
  • Received Date: 2023-10-25
  • Accepted Date: 2023-11-29
  • Published Date: 2024-07-25
  •   Objective  To investigate the association of sleep disorders with the development and progression of nonalcoholic fatty liver disease (NAFLD).  Methods  A total of 1 868 participants from the health examination cohort and fatty liver cohort of Beijing Friendship Hospital from June 2022 to June 2023 were enrolled as subjects. Related data were collected from all subjects, including age, sex, education level, chronic medical history, and biochemical parameters, and all subjects completed Pittsburgh Sleep Quality Index (PSQI) scale independently. According to the diagnostic criteria, the subjects were divided into non-NAFLD group with 1 122 subjects and NAFLD group with 746 subjects, and according to the stage of progression, the patients in the NAFLD group were further divided into simple fatty liver group (SFL group with 624 subjects) and nonalcoholic steatohepatitis (NASH) group with 122 subjects. A one-way analysis of variance or the Kruskal-Wallis H test was used for comparison of continuous data between three groups. The chi-square test was used for comparison of categorical data between the three groups. The binary Logistic regression analysis was used to investigate the association between sleep factors and NAFLD, and the multinomial Logistic regression analysis was used to investigate the association between sleep factors and the different stages of NAFLD; two multivariate models were constructed for adjustment of potential confounding factors, i.e., an age-sex adjustment model and a multivariate adjustment model, and the multivariate adjustment model adjusted the factors of age, sex, education level, smoking, diabetes, hypertension, body mass index (BMI), triglyceride (TG), and high-density lipoprotein cholesterol (HDL-C).  Results  There were significant differences in age, sex, BMI, education level, smoking, diabetes, hypertension, alanine aminotransferase, TG, and HDL-C between the non-NAFLD, SFL, and NASH groups (all P<0.05). There were also significant differences between the three groups in the total score of PSQI scale and the proportion of subjects with a score of 0‍ ‍—‍ ‍3 points for the 7 sleep components (all P<0.05). The multivariate adjustment model showed no significant association between sleep disorders and SFL, while long sleep latency (odds ratio [OR]=4.04, 95% confidence interval [CI]: 2.33‍ ‍—‍ ‍7.03, P<0.001), short sleep duration (OR=3.53, 95%CI: 1.83‍ ‍—‍ ‍6.82, P<0.001), and severe sleep disorders (OR=2.96, 95%CI: 1.48‍ ‍—‍ ‍5.93, P=0.002) were closely associated with the risk of NASH.  Conclusion  Overall sleep condition and its components of sleep disorders are not significantly associated with the simple fatty liver; however, long sleep latency, short sleep duration, and severe sleep disorders can increase the risk of NASH, which should be taken seriously in clinical practice.

     

  • loading
  • [1]
    RIAZI K, AZHARI H, CHARETTE JH, et al. The prevalence and incidence of NAFLD worldwide: A systematic review and meta-analysis[J]. Lancet Gastroenterol Hepatol, 2022, 7( 9): 851- 861. DOI: 10.1016/S2468-1253(22)00165-0.
    [2]
    PAIK JM, HENRY L, YOUNOSSI Y, et al. The burden of nonalcoholic fatty liver disease(NAFLD) is rapidly growing in every region of the world from 1990 to 2019[J]. Hepatol Commun, 2023, 7( 10): e0251. DOI: 10.1097/HC9.0000000000000251.
    [3]
    LING Z, ZHANG CC, HE J, et al. Association of healthy lifestyles with non-alcoholic fatty liver disease: A prospective cohort study in Chinese government employees[J]. Nutrients, 2023, 15( 3): 604. DOI: 10.3390/nu15030604.
    [4]
    HUANG DQ, NOUREDDIN N, AJMERA V, et al. Type 2 diabetes, hepatic decompensation, and hepatocellular carcinoma in patients with non-alcoholic fatty liver disease: An individual participant-level data meta-analysis[J]. Lancet Gastroenterol Hepatol, 2023, 8( 9): 829- 836. DOI: 10.1016/S2468-1253(23)00157-7.
    [5]
    JULIÁN MT, BALLESTA S, PERA G, et al. Abdominal obesity and dsyglycemia are risk factors for liver fibrosis progression in NAFLD subjects: A population-based study[J]. Front Endocrinol(Lausanne), 2022, 13: 1051958. DOI: 10.3389/fendo.2022.1051958.
    [6]
    DUAN D, KIM LJ, JUN JC, et al. Connecting insufficient sleep and insomnia with metabolic dysfunction[J]. Ann N Y Acad Sci, 2023, 1519( 1): 94- 117. DOI: 10.1111/nyas.14926.
    [7]
    National Workshop on Fatty Liver and Alcoholic Liver Disease, Chinese Society of Hepatology, Chinese Medical Association; Fatty Liver Expert Committee, Chinese Medical Doctor Association. Guidelines of prevention and treatment for nonalcoholic fatty liver disease: A 2018 update[J]. J Clin Hepatol, 2018, 34( 5): 947- 957. DOI: 10.3969/j.issn.1001-5256.2018.05.007.

    中华医学会肝病学分会脂肪肝和酒精性肝病学组, 中国医师协会脂肪性肝病专家委员会. 非酒精性脂肪性肝病防治指南(2018年更新版)[J]. 临床肝胆病杂志, 2018, 34( 5): 947- 957. DOI: 10.3969/j.issn.1001-5256.2018.05.007.
    [8]
    HU Y, LI HJ, ZHANG H, et al. ZSP1601, a novel pan-phosphodiesterase inhibitor for the treatment of NAFLD, A randomized, placebo-controlled phase Ib/IIa trial[J]. Nat Commun, 2023, 14( 1): 6409. DOI: 10.1038/s41467-023-42162-0.
    [9]
    ZHAO JJ, WANG QY, ZHAO XY, et al. Electro-acupuncture reduced steatosis on MRI-PDFF in patients with non-alcoholic steatohepatitis: A randomized controlled pilot clinical trial[J]. Chin Med, 2023, 18( 1): 19. DOI: 10.1186/s13020-023-00724-w.
    [10]
    MOLLAYEVA T, THURAIRAJAH P, BURTON K, et al. The Pittsburgh sleep quality index as a screening tool for sleep dysfunction in clinical and non-clinical samples: A systematic review and meta-analysis[J]. Sleep Med Rev, 2016, 25: 52- 73. DOI: 10.1016/j.smrv.2015.01.009.
    [11]
    NOBLE WS. How does multiple testing correction work?[J]. Nat Biotechnol, 2009, 27( 12): 1135- 1137. DOI: 10.1038/nbt1209-1135.
    [12]
    ZHOU JH, ZHOU F, WANG WX, et al. Epidemiological features of NAFLD from 1999 to 2018 in China[J]. Hepatology, 2020, 71( 5): 1851- 1864. DOI: 10.1002/hep.31150.
    [13]
    ZHOU F, ZHOU JH, WANG WX, et al. Unexpected rapid increase in the burden of NAFLD in China from 2008 to 2018: A systematic review and meta-analysis[J]. Hepatology, 2019, 70( 4): 1119- 1133. DOI: 10.1002/hep.30702.
    [14]
    YOUNOSSI ZM, COREY KE, LIM JK. AGA clinical practice update on lifestyle modification using diet and exercise to achieve weight loss in the management of nonalcoholic fatty liver disease: Expert review[J]. Gastroenterology, 2021, 160( 3): 912- 918. DOI: 10.1053/j.gastro.2020.11.051.
    [15]
    WANG CE, XU WT, GONG J, et al. Research progress in the treatment of non-alcoholic fatty liver disease[J]. Clin J Med Offic, 2022, 50( 9): 897- 899, 903. DOI: 10.16680/j.1671-3826.2022.09.06.

    王彩娥, 许文涛, 宫建, 等. 非酒精性脂肪性肝病治疗研究进展[J]. 临床军医杂志, 2022, 50( 9): 897- 899, 903. DOI: 10.16680/j.1671-3826.2022.09.06.
    [16]
    YU LB, LIN CL, CHEN XH, et al. A meta-analysis of sleep disorders and nonalcoholic fatty liver disease: Potential causality and symptom management[J]. Gastroenterol Nurs, 2022, 45( 5): 354- 363. DOI: 10.1097/SGA.0000000000000658.
    [17]
    MESARWI OA, LOOMBA R, MALHOTRA A. Obstructive sleep apnea, hypoxia, and nonalcoholic fatty liver disease[J]. Am J Respir Crit Care Med, 2019, 199( 7): 830- 841. DOI: 10.1164/rccm.201806-1109TR.
    [18]
    WANG HL, GU YQ, ZHENG LX, et al. Association between bedtime and the prevalence of newly diagnosed non-alcoholic fatty liver disease in adults[J]. Liver Int, 2018, 38( 12): 2277- 2286. DOI: 10.1111/liv.13896.
    [19]
    ZAREAN E, LOOHA MA, AMINI P, et al. Sleep characteristics of middle-aged adults with non-alcoholic fatty liver disease: Findings from the Shahrekord PERSIAN cohort study[J]. BMC Public Health, 2023, 23( 1): 312. DOI: 10.1186/s12889-023-15251-4.
    [20]
    LIU HW, HUANG SL, XU MD, et al. The association between sleep duration, quality, and nonalcoholic fatty liver disease: A cross-sectional study[J]. Open Med(Wars), 2023, 18( 1): 20230670. DOI: 10.1515/med-2023-0670.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(1)  / Tables(3)

    Article Metrics

    Article views (207) PDF downloads(42) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return